The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Open accessAbstract
For several decades scientists have speculated that the key to understanding age-related neurodegenerative disorders may be found in the unusual biology of the prion diseases. Recently, owing largely to the advent of new disease models, this hypothesis has gained experimental momentum. In a remarkable variety of diseases, specific proteins have been found to misfold and aggregate into seeds that structurally corrupt like proteins, causing them to aggregate and form pathogenic assemblies ranging from small oligomers to large masses of amyloid. Proteinaceous seeds can therefore serve as self-propagating agents for the instigation and progression of disease. Alzheimer's disease and other cerebral proteopathies seem to arise from the de novo misfolding and sustained corruption of endogenous proteins, whereas prion diseases can also be infectious in origin. However, the outcome in all cases is the functional compromise of the nervous system, because the aggregated proteins gain a toxic function and/or lose their normal function. As a unifying pathogenic principle, the prion paradigm suggests broadly relevant therapeutic directions for a large class of currently intractable diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The recent discovery that specific misfolded and aggregated proteins can propagate and spread in a prion-like fashion has sparked considerable interest (67).”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [67]
In the citing paper
“In Parkinson’s disease and Lewy body disease, α-synuclein aggregates initially spread through the brainstem and olfactory bulb followed by limbic structures, and only thence to the neocortex.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [67]
In the citing paper
“In each of these cases, the aggregates initially deposit at the ventral base of the forebrain and midbrain, and then extend rostrally and dorsally to the cortex.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [67]
In the citing paper
“While still a contentious topic [46], there is now substantial evidence that also supports the idea that propagation of pathological tau species occurs between cells [47–50].”
From Glial contributions to neurodegeneration in tauopathies (2017) · cites this paper as [50]
In the citing paper
“As aforementioned, the neuropathological lesions of not only AD but also PD/DLB and amyotrophic lateral sclerosis (ALS) are known to spread through the brain in a rather specific pattern, which also serves as a basis for the neuropathological staging of disease severity [203].”
From α-synuclein in the pathophysiology of Alzheimer’s disease (2019) · cites this paper as [203]
In the citing paper
“Importantly, the spatiotemporal spread of αSyn lesions in PD/DLB is nearly inverted to the spread of Aβ and tau pathology as observed in AD [203].”
From α-synuclein in the pathophysiology of Alzheimer’s disease (2019) · cites this paper as [203]
In the citing paper
“pathological neurofibrillary Tau aggregates show a pattern of accumulation that starts in the entorhinal cortex and spreads through connected pathways to cortical areas (Jucker and Walker, 2013)”
From Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease (2020) · cites this paper as Jucker and Walker, 2013
In the citing paper
“It has been suggested that alpha-synuclein could act like a prion protein during PD pathogenesis.In this theory pathologic, misfolded alpha-synuclein is an 'infectious' protein spreading pathology by forming a template that seeds misfolding for nearby alpha-synuclein protein, turning the previously healthy protein into a pathogenic protein (Jucker and Walker, 2013;Visanji et al., 2013).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Jucker and Walker, 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,497
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Molecular chaperones in protein folding and proteostasis
Hartl, F. U., Bracher, A., & Hayer-Hartl, M. (2011) · Nature · doi:10.1038/nature10317 · Cited by 3,381
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,000
Avidity within the N‐terminal anchor drives α‐synuclein membrane interaction and insertion
Cholak, E., Bugge, K., Khondker, A., Gauger, K., Pedraz‐Cuesta, E., Pedersen, M. E., Bucciarelli, S., Vestergaard, B., Pedersen, S. F., Rheinstadter, M. C., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000107r · Cited by 44
Thioflavin T templates amyloid β(1–40) conformation and aggregation pathway
Carlo, M. G. D., Minicozzi, V., Foderà, V., Militello, V., Vetri, V., Morante, S., & Leone, M. (2015) · Biophysical Chemistry · doi:10.1016/j.bpc.2015.06.006 · Cited by 44
Emerging roles of O-glycosylation in regulating protein aggregation, phase separation, and functions
Li, X., Lv, P., Du, Y., Chen, X., & Liu, C. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102314 · Cited by 43
Mead, S., Burnell, M., Lowe, J., Thompson, A. G. B., Lukić, A., Porter, M., Carswell, C. J., Kaski, D. N., Kenny, J., Mok, T. H., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.4885 · Cited by 43
Gudde, A. E. E. G., González‐Barriga, A., van den Broek, W. J. A. A., Wieringa, B., & Wansink, D. G. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw042 · Cited by 43
Prion-like mechanisms in amyotrophic lateral sclerosis
Ayers, J. I., & Cashman, N. R. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00018-0 · Cited by 44
The interplay of biochemical and biomechanical degeneration in Alzheimer’s disease
Schäfer, A., Weickenmeier, J., & Ellen Kuhl, A. (2019) · Computer Methods in Applied Mechanics and Engineering · doi:10.1016/j.cma.2019.04.028 · Cited by 43
Hao, S., Li, X., Han, A., Yang, Y., Fang, G., Liu, J., & Wang, S. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00469 · Cited by 43
Mehrabadi, S., Motevaseli, E., Sadr, S. S., & Moradbeygi, K. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112362 · Cited by 43
Studying the Pathophysiology of Parkinson’s Disease Using Zebrafish
Barnhill, L. M., Murata, H., & Bronstein, J. M. (2020) · Biomedicines · doi:10.3390/biomedicines8070197 · Cited by 44
Farina, S., Esposito, F., Battistoni, M., Biamonti, G., & Francia, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.693325 · Cited by 46
Global brain activity and its coupling with cerebrospinal fluid flow is related to tau pathology
Han, F., Lee, J., Chen, X., Ziontz, J., Ward, T. J., Landau, S. M., Baker, S. L., Harrison, T. M., Jagust, W. J., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14296 · Cited by 42
Layers of structure and function in protein aggregation
Tanaka, M., & Komi, Y. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1818 · Cited by 43
Single Mutations in Tau Modulate the Populations of Fibril Conformers through Seed Selection
Meyer, V., Dinkel, P. D., Luo, Y., Yu, X., Wei, G., Zheng, J., Eaton, G. R., Ma, B., Nussinov, R., Eaton, S. S., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308473 · Cited by 42
Molecular pathogenesis of human amyloidosis: Lessons from β2‐microglobulin‐related amyloidosis
Naiki, H., Okoshi, T., Ozawa, D., Yamaguchi, I., & Hasegawa, K. (2016) · Pathology International · doi:10.1111/pin.12394 · Cited by 42
A method for inferring regional origins of neurodegeneration
Torok, J., Maia, P. D., Powell, F., Pandya, S., & Raj, A. (2017) · Brain · doi:10.1093/brain/awx371 · Cited by 42
Mechanism of aggregation and membrane interactions of mammalian prion protein
Thody, S. A., Mathew, M. K., & Udgaonkar, J. B. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.02.031 · Cited by 42
Timmers, M., Tesseur, I. C., Bogert, J., Zetterberg, H., Blennow, K., Börjesson‐Hanson, A., Baquero, M., Boada, M., RANDOLPH, C. C., Tritsmans, L., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.03.016 · Cited by 43
Ding, X., Xiang, Z., Qin, C., Chen, Y., Tian, H., Lin, M., Xia, D., Liu, H., Song, J. T., Fu, J., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01112-3 · Cited by 43
Extracellular protein homeostasis in neurodegenerative diseases
Wilson, M. R., Satapathy, S., & Vendruscolo, M. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00786-2 · Cited by 43
Kulikova, A. A., Cheglakov, I. B., Kukharsky, M. S., Ovchinnikov, R. K., Kozin, S. A., & Makarov, A. А. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9603-y · Cited by 41
Aggarwal, T., Polanco, M. J., Scaramuzzino, C., Rocchi, A., Milioto, C., Emionite, L., Ognio, E., Sambataro, F., Galbiati, M., Poletti, A., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.004 · Cited by 42
Structural studies on the mechanism of protein aggregation in age related neurodegenerative diseases
Eftekharzadeh, B., Hyman, B. T., & Wegmann, S. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.03.001 · Cited by 44
Electrostatic Complementarity Drives Amyloid/Nucleic Acid Co‐Assembly
Rha, A. K., Das, D., Taran, O., Ke, Y., Mehta, A. K., & Lynn, D. G. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201907661 · Cited by 41
Annadurai, N., Sanctis, J. B. D., Hajdúch, M., & Das, V. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113756 · Cited by 41
The Myelin‐Weighted Connectome in Parkinson's Disease
Boshkovski, T., Cohen‐Adad, J., Mišić, B., Arnulf, I., Corvol, J., Vidailhet, M., Lehéricy, S., Stikov, N., & Mancini, M. (2021) · Movement Disorders · doi:10.1002/mds.28891 · Cited by 41
Single cell transcriptomic profiling of a neuron-astrocyte assembloid tauopathy model
Rickner, H., Jiang, L., Hong, R., O’Neill, N. K., Mojica, C. A., Snyder, B. J., Zhang, L., Shaw, D., Medalla, M., Wolozin, B. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34005-1 · Cited by 43
Proteolysis triggers self-assembly and unmasks innate immune function of a human α-defensin peptide
Chairatana, P., Chu, H., Castillo, P. A., Shen, B., Bevins, C. L., & Nolan, E. M. (2015) · Chemical Science · doi:10.1039/c5sc04194e · Cited by 41
EEG resting-state networks in Alzheimer’s disease associated with clinical symptoms
Aoki, Y., Takahashi, R., Suzuki, Y., Pascual-Marqui, R. D., Kito, Y., Hikida, S., Maruyama, K., Hata, M., Ishii, R., Iwase, M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-30075-3 · Cited by 40
Membrane-induced tau amyloid fibrils
Mammeri, N. E., Gampp, O., Duan, P., & Hong, M. (2023) · Communications Biology · doi:10.1038/s42003-023-04847-6 · Cited by 46
Super-resolution imaging unveils the self-replication of tau aggregates upon seeding
Dimou, E., Katsinelos, T., Meisl, G., Tuck, B. J., Keeling, S., Smith, A. E., Hidari, E., Lam, J. Y. L., Burke, M., Lövestam, S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112725 · Cited by 43
Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis
Margoni, M., Pagani, E., Meani, A., Preziosa, P., Mistri, D., Gueye, M., Moiola, L., Filippi, M., & Rocca, M. A. (2024) · Annals of Neurology · doi:10.1002/ana.26911 · Cited by 40
Risse, E., Nicoll, A. J., Taylor, W. A., Wright, D., Badoni, M., Yang, X., Farrow, M. A., & Collinge, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.637124 · Cited by 43
Schweighauser, M., Bacioglu, M., Fritschi, S. K., Shimshek, D. R., Kahle, P. J., Eisele, Y. S., & Jucker, M. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1360-5 · Cited by 40
Self-citationRebels with a cause: molecular features and physiological consequences of yeast prions
Garcia, D. M., & Jarosz, D. F. (2013) · FEMS Yeast Research · doi:10.1111/1567-1364.12116 · Cited by 43
Unfolded Protein Response and Macroautophagy in Alzheimer’s, Parkinson’s and Prion Diseases
Milisav, I., Šuput, D., & Ribarič, S. (2015) · Molecules · doi:10.3390/molecules201219865 · Cited by 42
Critical appraisal of pathology transmission in the α-synuclein fibril model of Lewy body disorders
Nouraei, N., Mason, D. M., Miner, K. M., Carcella, M. A., Bhatia, T. N., Dumm, B. K., Soni, D., Johnson, D. A., Luk, K. C., & Leak, R. K. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.10.017 · Cited by 42
Saied, I., Arslan, T., Chandran, S., Smith, C., Spires‐Jones, T. L., & Pal, S. (2020) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2020.3011359 · Cited by 44
Lazarev, V. F., Tsolaki, M., Mikhaylova, E. R., Benken, K. A., Shevtsov, M. A., Nikotina, A. D., Lechpammer, M., Mitkevich, V. A., Makarov, A. А., Moskalev, A., et al. (2021) · Aging and Disease · doi:10.14336/ad.2020.1230 · Cited by 41
Tau induces formation of α-synuclein filaments with distinct molecular conformations
Hojjatian, A., Dasari, A. K. R., Sengupta, U., Taylor, D. W., Daneshparvar, N., Yeganeh, F. A., Dillard, L. B., Michael, B. C., Griffin, R. G., Borgnia, M. J., et al. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.091 · Cited by 41
Zhang, S., Li, J., Xu, Q., Xia, W., Tao, Y., Shi, C., Li, D., Xiang, S., & Liu, C. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c10854 · Cited by 40
Bhattacharya, S., Maelicke, A., & Montag, D. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142421 · Cited by 39
5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors
Ai, T., Wilson, D. J., More, S. S., Xie, J., & Chen, L. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01376 · Cited by 39
CSF biomarkers in neurodegenerative and vascular dementias
Llorens, F., Schmitz, M., Ferrer, I., & Zerr, I. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.03.003 · Cited by 44
Sialylation Controls Prion Fate in Vivo
Srivastava, S., Katorcha, E., Daus, M. L., Lasch, P., Beekes, M., & Baskakov, I. V. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.768010 · Cited by 39
Haghshomar, M., Dolatshahi, M., Sherbaf, F. G., Moghaddam, H. S., Shandiz, M. S., & Aarabi, M. H. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00598 · Cited by 39
Perrault syndrome type 3 caused by diverse molecular defects in CLPP
Brodie, E. J., Zhan, H., Saiyed, T., Truscott, K. N., & Dougan, D. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-30311-1 · Cited by 39
Anti-amyloid Therapy of Alzheimer’s Disease: Current State and Prospects
Kozin, S. A., Barykin, E. P., Mitkevich, V. A., & Makarov, A. А. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918090079 · Cited by 39
Barykin, E., Garifulina, A. I., Kruykova, E. V., Spirova, E., Anashkina, A., Adzhubei, A., Shelukhina, I., Kasheverov, I., Mitkevich, V., Kozin, S., et al. (2019) · Cells · doi:10.3390/cells8080771 · Cited by 36
Manganese Exposure Aggravates β-Amyloid Pathology by Microglial Activation
Lin, G., Li, X., Cheng, X., Zhao, N. O., & Zheng, W. H. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.556008 · Cited by 40
Mitić, M., & Pašti, T. D. L. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1931681 · Cited by 39
Mechanisms That Activate 26S Proteasomes and Enhance Protein Degradation
Goldberg, A. L., Kim, H. T., Lee, D. H., & Collins, G. A. (2021) · Biomolecules · doi:10.3390/biom11060779 · Cited by 42
Molecular structure of an amyloid fibril formed by FUS low-complexity domain
Sun, Y., Zhang, S., Hu, J., Tao, Y., Xia, W., Gu, J., Li, Y., Cao, Q., Li, D., & Liu, C. (2021) · iScience · doi:10.1016/j.isci.2021.103701 · Cited by 39
Structure-activity relationship of carbon nitride dots in inhibiting Tau aggregation
Zhou, Y., Kandel, N., Bartoli, M., Serafim, L. F., ElMetwally, A. E., Falkenberg, S. M., Paredes, X. E., Nelson, C. J., Smith, N. S., Padovano, E., et al. (2022) · Carbon · doi:10.1016/j.carbon.2022.03.021 · Cited by 39
Connecting the Dots: Macromolecular Crowding and Protein Aggregation
Siddiqui, G. A., & Naeem, A. (2022) · Journal of Fluorescence · doi:10.1007/s10895-022-03082-2 · Cited by 39
Lung endothelium, tau, and amyloids in health and disease
Balczon, R., Lin, M. T., Voth, S. B., Nelson, A. R., Schupp, J. C., Wagener, B. M., Pittet, J., & Stevens, T. (2023) · Physiological Reviews · doi:10.1152/physrev.00006.2023 · Cited by 40
Li, D., & Liu, C. (2023) · Structure · doi:10.1016/j.str.2023.08.006 · Cited by 39
Prion-like polymerization as a signaling mechanism
Cai, X., & Chen, Z. J. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.10.003 · Cited by 38
Ma, Q., Huang, B., Wang, J., Seger, C. A., Yang, W., Li, C., Wang, J., Feng, J., Weng, L., Jiang, W., et al. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9524-7 · Cited by 38
Linsley, J. W., Tripathi, A., Epstein, I., Schmunk, G., Mount, E., Campioni, M. R., Oza, V. D., Barch, M., Javaherian, A., Nowakowski, T. J., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0411-9 · Cited by 41
Bifunctional ligand design for modulating mutant p53 aggregation in cancer
Miller, J. J., Blanchet, A., Orvain, C., Nouchikian, L., Reviriot, Y., Clarke, R. M., Martelino, D., Wilson, D. J., Gaiddon, C., & Storr, T. (2019) · Chemical Science · doi:10.1039/c9sc04151f · Cited by 40
Candreva, J., Chau, E., Rice, M. E., & Kim, J. R. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00655 · Cited by 39
Posttranslational modifications define course of prion strain adaptation and disease phenotype
Makarava, N., Chang, J. C., Molesworth, K., & Baskakov, I. V. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138677 · Cited by 39
α-Synuclein aggregation and transmission in Parkinson’s disease: a link to mitochondria and lysosome
Wang, R., Sun, H., Ren, H., & Wang, G. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1756-9 · Cited by 38
Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target
Gu, J., & Liu, F. (2020) · Current Medical Science · doi:10.1007/s11596-020-2282-1 · Cited by 41
Human tauopathy-derived tau strains determine the substrates recruited for templated amplification
Tarutani, A., Miyata, H., Nonaka, T., Hasegawa, K., Yoshida, M., Saito, Y., Murayama, S., Robinson, A., Mann, D. M. A., Tomita, T., et al. (2021) · Brain · doi:10.1093/brain/awab091 · Cited by 37
Landureau, M., Redeker, V., Bellande, T., Eyquem, S., & Melki, R. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100737 · Cited by 40
Shen, J., Lü, Z., Wang, J., Hao, Q., Ji, W., Wu, Y., Peng, H., Zhao, R., Yang, J., Li, Y., et al. (2021) · Advanced Materials · doi:10.1002/adma.202101993 · Cited by 38
The neuromicrobiology of Parkinson’s disease: A unifying theory
Muñoz, M., Empadinhas, N., & Cardoso, S. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101396 · Cited by 38
A systematic investigation of production of synthetic prions from recombinant prion protein
Schmidt, C., Fizet, J., Properzi, F., Batchelor, M., Sandberg, M. K., Edgeworth, J. A., Afran, L., Ho, S., Badhan, A., Klier, S., et al. (2015) · Open Biology · doi:10.1098/rsob.150165 · Cited by 38
Arnsten, A. F. T., Tredici, K. D., Barthélemy, N. R., Gabitto, M. I., van Dyck, C. H., Lein, E. S., Braak, H., & Datta, D. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70404 · Cited by 39
Metabolite amyloids: a new paradigm for inborn error of metabolism disorders
Gazit, E. (2016) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-016-9946-9 · Cited by 37
Masnata, M., & Cicchetti, F. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00647 · Cited by 39
Predictive Model of Spread of Progressive Supranuclear Palsy Using Directional Network Diffusion
Pandya, S., Mezias, C., & Raj, A. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00692 · Cited by 39
Cytotoxic species in amyloid-associated diseases: Oligomers or mature fibrils
Siddiqi, M. K., Malik, S., Majid, N., Alam, P., & Khan, R. H. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.06.001 · Cited by 38
Amro, Z., Yool, A. J., & Collins‐Praino, L. E. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100242 · Cited by 39
Theme and variations: evolutionary diversification of the HET-s functional amyloid motif
Daskalov, A., Dyrka, W., & Saupe, S. J. (2015) · Scientific Reports · doi:10.1038/srep12494 · Cited by 37
Basu, S., Je, G., & Kim, Y. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.54 · Cited by 39
The molecular basis of Alzheimer's plaques
Pospich, S., & Raunser, S. (2017) · Science · doi:10.1126/science.aap8002 · Cited by 37
Polini, B., Ricardi, C., Bertolini, A., Carnicelli, V., Rutigliano, G., Saponaro, F., Zucchi, R., & Chiellini, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411569 · Cited by 37
Daraban, B. S., Popa, A. S., & Stan, M. S. (2024) · Molecules · doi:10.3390/molecules29174056 · Cited by 37
Lab-on-a-brain: Implantable micro-optical fluidic devices for neural cell analysis in vivo
Takehara, H., Nagaoka, A., Noguchi, J., Akagi, T., Kasai, H., & Ichiki, T. (2014) · Scientific Reports · doi:10.1038/srep06721 · Cited by 36
An Enhanced Genetic Algorithm for Ab Initio Protein Structure Prediction
Rashid, M. A., Khatib, F., Hoque, M. T., & Sattar, A. (2015) · IEEE Transactions on Evolutionary Computation · doi:10.1109/tevc.2015.2505317 · Cited by 36
Strain-specific Fibril Propagation by an Aβ Dodecamer
Dean, D. N., Das, P. K., Rana, P., Burg, F., Levites, Y., Morgan, S. E., Ghosh, P., & Rangachari, V. (2017) · Scientific Reports · doi:10.1038/srep40787 · Cited by 36
Calpain-2 as a therapeutic target for acute neuronal injury
Wang, Y., Bi, X., & Baudry, M. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1409723 · Cited by 37
Amyloid‐Like Fibrillary Morphology Originated by Tyrosine‐Containing Aromatic Hexapeptides
Diaferia, C., Balasco, N., Sibillano, T., Ghosh, M., Adler‐Abramovich, L., Giannini, C., Vitagliano, L., Morelli, G., & Accardo, A. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201800351 · Cited by 36
Cellular mechanisms responsible for cell-to-cell spreading of prions
Vilette, D., Courte, J., Peyrin, J., Coudert, L., Schaeffer, L., Andréoletti, O., & Leblanc, P. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2823-y · Cited by 43
Physiological and pathological functions of LRRK2: implications from substrate proteins
Araki, M., Ito, G., & Tomita, T. (2018) · Neuronal Signaling · doi:10.1042/ns20180005 · Cited by 37
Role of Rab GTPases in Alzheimer’s Disease
Zhang, X., Huang, T. Y., Yancey, J., Luo, H., & Zhang, Y. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00387 · Cited by 37
Cytoplasmic Restriction of Mutated SOD1 Impairs the DNA Repair Process in Spinal Cord Neurons
Li, J., Song, M., Moh, S.-H., Kim, H., & Kim, D.-H. (2019) · Cells · doi:10.3390/cells8121502 · Cited by 37
Kiechle, M., von Einem, B., Höfs, L., Voehringer, P., Grozdanov, V., Markx, D., Parlato, R., Wiesner, D., Mayer, B., Sakk, O., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.089 · Cited by 36
Formation of distinct prion protein amyloid fibrils under identical experimental conditions
Žiaunys, M., Šneideris, T., & Smirnovas, V. (2020) · Scientific Reports · doi:10.1038/s41598-020-61663-2 · Cited by 36
Molecular Spectroscopic Markers of Abnormal Protein Aggregation
Wilkosz, N., Czaja, M., Seweryn, S., Skirlińska‐Nosek, K., Szymoński, M., Lipiec, E. W., & Sofińska, K. (2020) · Molecules · doi:10.3390/molecules25112498 · Cited by 37
The chaperone HSPB1 prepares protein aggregates for resolubilization by HSP70
Gonçalves, C. C., Sharon, I., Schmeing, T. M., Ramos, C. H. I., & Young, J. C. (2021) · Scientific Reports · doi:10.1038/s41598-021-96518-x · Cited by 39
The chaperone Clusterin in neurodegeneration−friend or foe?
Yuste‐Checa, P., Bracher, A., & Hartl, F. U. (2022) · BioEssays · doi:10.1002/bies.202100287 · Cited by 37
Chhangani, D., Upadhyay, A., Amanullah, A., Joshi, V., & Mishra, A. (2014) · Scientific Reports · doi:10.1038/srep05077 · Cited by 36
Alzheimer Peptides Aggregate into Transient Nanoglobules That Nucleate Fibrils
Luo, J., Wärmländer, S. K. T. S., Gräslund, A., & Abrahams, J. P. (2014) · Biochemistry · doi:10.1021/bi5003579 · Cited by 39
Pansieri, J., Halim, M. A., Vendrely, C., Dumoulin, M., Legrand, F., Sallanon, M. M., Chierici, S., Denti, S., Dagany, X., Dugourd, P., et al. (2018) · Chemical Science · doi:10.1039/c7sc04542e · Cited by 36
Liu, Z., Zou, Y. F., Zhang, Q., Chen, P., Liu, Y., & Qian, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20082048 · Cited by 36
Chronic Traumatic Encephalopathy: Is Latency in Symptom Onset Explained by Tau Propagation?Preprint
Kriegel, J., Papadopoulos, Z., & McKee, A. C. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024059 · Cited by 38
Metadata
- Authors
- Jucker, M., & Walker, L. C.
- Affiliations
- Hertie Institute for Clinical Brain Research (DE)
- Emory University (US)
- Corresponding author
- Jucker, Mathias
- Walker, Lary C.
- Venue
- Nature
- Published
- 2013-09-04
- Volume
- 501
- Issue
- 7465
- Pages
- 45-51
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3963807
- OpenAlex
- W2034147064
- Cited by
- 1,663
- References
- 126
- Citations by year
- 2026: 82 · 2025: 113 · 2024: 114 · 2023: 111 · 2022: 119 · 2021: 161 · 2020: 140 · 2019: 153 · 2018: 131 · 2017: 166 · 2016: 147 · 2015: 119 · 2014: 101 · 2013: 6
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DZNE Pub (submittedVersion)
- Funders
- National Institutes of Health (P51OD011132)
- National Institute on Aging (R21AG040589)
- National Center for Research Resources (P51RR165, P51RR000165)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- protein aggregation, seeded aggregation, neurodegenerative diseases, prion disease, Alzheimer's disease, Parkinson's disease, Creutzfeldt-Jakob disease, protein misfolding, amyloid, oligomers, proteinopathies, disease models, neurodegeneration therapy
- MeSH terms
- Alzheimer Disease, Amyloid, Animals, Humans, Prions, tau Proteins, Prion Diseases, Neurodegenerative Diseases, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
